1. Home
  2. RH vs CPRX Comparison

RH vs CPRX Comparison

Compare RH & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RH

RH

RH

HOLD

Current Price

$127.89

Market Cap

2.8B

ML Signal

HOLD

Logo Catalyst Pharmaceuticals Inc.

CPRX

Catalyst Pharmaceuticals Inc.

HOLD

Current Price

$22.54

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RH
CPRX
Founded
1979
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.0B
IPO Year
2011
2006

Fundamental Metrics

Financial Performance
Metric
RH
CPRX
Price
$127.89
$22.54
Analyst Decision
Hold
Strong Buy
Analyst Count
16
1
Target Price
$225.00
$35.00
AVG Volume (30 Days)
1.0M
1.0M
Earning Date
04-02-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.24
EPS
4.84
1.68
Revenue
$1,193,046,000.00
$119,072,803.00
Revenue This Year
$12.43
$8.00
Revenue Next Year
$8.92
$9.77
P/E Ratio
$27.75
$13.28
Revenue Growth
24.52
16.39
52 Week Low
$123.03
$19.05
52 Week High
$264.58
$26.56

Technical Indicators

Market Signals
Indicator
RH
CPRX
Relative Strength Index (RSI) 26.58 38.69
Support Level N/A $22.25
Resistance Level $224.32 $24.94
Average True Range (ATR) 6.69 0.69
MACD -0.44 -0.21
Stochastic Oscillator 0.99 12.84

Price Performance

Historical Comparison
RH
CPRX

About RH RH

RH is a luxury furniture and lifestyle retailer primarily operating in the $136 billion domestic furniture and home furnishing industry. The firm offers merchandise across many categories, including furniture, lighting, textiles, bath, decor, and is growing the presence of its hospitality business with 24 restaurant locations, including RH Guesthouse. RH innovates, curates, and integrates products, categories, services, and businesses across channels and brand extensions (RH Modern and Waterworks, for example). RH is fully integrated across channels and is positioned to broaden its addressable market over the next decade via expanding abroad, its World of RH digital platform (highlighting offerings outside of home furnishings), and offerings in architecture, media, and more.

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.

Share on Social Networks: